Is LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 50.2% / 30% | 3.2% / 30% | 16.7% / 30% | 3.75% / 5% | ✗ NOT HALAL |
| DJIM | 50.2% / 33% | 3.2% / 33% | 16.7% / 33% | 3.75% / 5% | ✗ NOT HALAL |
| MSCI | 54.7% / 33% | 3.5% / 33% | 18.2% / 33% | 3.75% / 5% | ✗ NOT HALAL |
| S&P | 50.2% / 33% | 3.2% / 33% | 16.7% / 33% | 3.75% / 5% | ✗ NOT HALAL |
| FTSE | 54.7% / 33% | 3.5% / 33% | 18.2% / 50% | 3.75% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 31.4% | |
| Operating Margin | 8.2% | |
| Net Margin | -23.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$206,000 |
| Free Cash Flow | -$14M |
| Total Debt | $143M |
| Debt-to-Equity | 414.8 |
| Current Ratio | 3.5 |
| Total Assets | $232M |
Price & Trading
| Last Close | $3.87 |
| 50-Day MA | $6.88 |
| 200-Day MA | $7.34 |
| Avg Volume | 219K |
| Beta | 0.6 |
|
52-Week Range
$3.64
| |
About LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), LIFECORE BIOMEDICAL, INC. \DE\ is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is LIFECORE BIOMEDICAL, INC. \DE\'s debt ratio?
LIFECORE BIOMEDICAL, INC. \DE\'s debt ratio is 50.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 54.7%.
What are LIFECORE BIOMEDICAL, INC. \DE\'s key financial metrics?
LIFECORE BIOMEDICAL, INC. \DE\ has a market capitalization of $137M, and revenue of $129M. The company maintains a gross margin of 31.4% and a net margin of -23.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.